Table 1. Storage conditions requested by guideline ICH Q1A for the development of new drug products.

Study	Storage condition	Minimum time period covered by data at submission
Long term*	25°C ±2°C/60% RH ±5% RH or 30°C ±2°C/65% RH ±5% RH	12 months
Intermediate**	30°C ±2°C/65% RH ±5% RH	6 months
Accelerated	40°C ±2°C/75% RH ±5% RH	6 months

^*It is up to the applicant to decide whether long term stability studies are performed at 25°C ±2°C/60% RH ±5% RH or 30°C ±2°C/65% RH ±5% RH.

^**If 30°C ±2°C/65% RH ±5% RH is the long-term condition, there is no intermediate condition.